Using the MR-Base platform to investigate risk factors and drug targets for thousands of phenotypes (2019)

First Author: Walker V

Attributed to: Reproductive and cardio-metabolic health funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.15334.1

Publication URI: http://dx.doi.org/10.12688/wellcomeopenres.15334.1

Type: Journal Article/Review

Parent Publication: Wellcome Open Research

ISSN: 2398-502X